Summary
NYSE Biotechnology Index is a stock index: one number that says how a chosen group of companies is doing together. An index cannot be bought itself; you buy a fund that tracks it.
What speaks for it
- Average yearly growth over the last three years: 22%.
What to watch
Nothing here calls for caution.
An index has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company.
Price
Performance
- 1 month
- +0.3%
- 3 months
- +13%
- This year
- +25%
- 1 year
- +38%
- 3 years
- +83%
Where is it within the last year?
Near the yearly high- Against the 50-day average
- +2.1%
- Against the 200-day average
- +15%
It is 2.6% below its highest and 37% above its lowest of the last year. The long-term trend points up: it is above its 200-day average.
How has it done?
Growing over the long run- A year on average, 3 years
- +22%
- Deepest drop
- -25%
- Yearly volatility
- 23%
Average yearly growth over the last three years: 22%. Deepest drop in these years: 25% below the earlier high.